For purchasing or obtaining a quotation, please visit the Distributor page
to find your local distributor.
to find your local distributor.
HOME > Product search results
Product（862）
[-] MHC tetramer（862）
>Class I（862）
Refine your search
[+]Animal species
[+]Category
[+]Conjugate
[+]MHC Allele
[+]Research area
[+]Tools
[+]Brands
[+]Availability (in Japan)
| Clip | Code No. | Product | Data | |||
|---|---|---|---|---|---|---|
| Data
Sheet |
Category | Conjugate | MHC Allele | Size | Availability | |
| Sequence | Location (aa) | Storage
temp. |
||||
|
|
||||||
|
TS-M230-2 |
HLA-A*02:01 USP28 Neoepitope Tetramer-LIIPFIHLI-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LIIPFIHLI | ４°C | |||||
|
|
TC-8033-2 |
HLA-A*03:01 KRAS8-16 WT Tetramer-VVGAGGVGK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVGAGGVGK | 8-16 | ４°C | ||||
|
|
TC-8019-2 |
HLA-A*02:01 MAGE-A2112-120 Tetramer-KMVELVHFL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KMVELVHFL | 112-120 | ４°C | ||||
|
|
TS-M217-2 |
HLA-A*02:01 ME3 Neoepitope Tetramer-FLDEFMEGV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLDEFMEGV | ４°C | |||||
|
|
TS-M255-2 |
HLA-A*03:01 ATR Neoepitope Tetramer-KLYEEPLLK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| KLYEEPLLK | ４°C | |||||
|
|
TS-M261-1 |
HLA-A*11:01 MATN2 Neoepitope Tetramer-KTLTSVFQK-PE |
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| KTLTSVFQK | ４°C | |||||
|
|
TS-M258-1 |
HLA-A*11:01 KRAS Neoepitope Tetramer-VVGAAGVGK-PE |
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVGAAGVGK | ４°C | |||||
|
|
TC-8011-1 |
HLA-A*02:01 KRAS5-14 G12V Tetramer-KLVVVGAVGV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVVVGAVGV | 5-14 | ４°C | ||||
|
|
TS-M268-2 |
HLA-A*24:02 p53 Tetramer-TYSPALNKMF-APC |
|
|||
|
|
cancer | APC | A*24:02 | 50 tests |
0 (Contact us) |
|
| TYSPALNKMF | 125-134 | ４°C | ||||
|
|
TS-M273-2 |
HLA-B*07:02 TTBK2 Neoepitope Tetramer-RPHHDQRSL-APC |
|
|||
|
|
cancer | APC | B*07:02 | 50 tests |
0 (Contact us) |
|
| RPHHDQRSL | ４°C | |||||
|
|
TS-M248-2 |
HLA-A*02:01 Insulin Tetramer-ALWGPDPAAA-APC |
|
|||
|
|
Others | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALWGPDPAAA | 15-24 | ４°C | ||||
|
|
TS-M247-1 |
HLA-A*02:01 AGMO Neoepitope Tetramer-ALLQVTLLL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALLQVTLLL | ４°C | |||||
|
|
TC-8017-2 |
HLA-A*02:01 AFP158-166 Tetramer-FMNKFIYEI-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FMNKFIYEI | 158-166 | ４°C | ||||
|
|
TC-8021-1 |
HLA-A*11:01 KRAS7-16 G12A Tetramer-VVVGAAGVGK-PE |
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGAAGVGK | 7-16 | ４°C | ||||
|
|
TS-M274-2 |
HLA-B*07:02 Filamin A Neoepitope Tetramer-CVRVSGQGL-APC |
|
|||
|
|
cancer | APC | B*07:02 | 50 tests |
0 (Contact us) |
|
| CVRVSGQGL | ４°C | |||||
|
|
TS-M265-2 |
HLA-A*24:02 β-catenin Neoepitope Tetramer-SYLDSGIHF-APC |
|
|||
|
|
cancer | APC | A*24:02 | 50 tests |
0 (Contact us) |
|
| SYLDSGIHF | ４°C | |||||
|
|
TS-M260-1 |
HLA-A*11:01 CDK13 Neoepitope Tetramer-CILGKLFTK-PE |
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| CILGKLFTK | ４°C | |||||
|
|
TS-M225-1 |
HLA-A*02:01 Hsp70 Neoepitope Tetramer-SLFEGIDIYT-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLFEGIDIYT | ４°C | |||||
|
|
TS-M266-2 |
HLA-A*24:02 COASY Neoepitope Tetramer-RFLEYLPLRF-APC |
|
|||
|
|
cancer | APC | A*24:02 | 50 tests |
0 (Contact us) |
|
| RFLEYLPLRF | ４°C | |||||
|
|
TS-M234-2 |
HLA-A*02:01 GAS7 Neoepitope Tetramer-SLADEAEVYL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLADEAEVYL | ４°C | |||||
|
|
TS-M203-2 |
HLA-A*02:01 HPV16 E7 Tetramer-LLMGTLGIV-APC |
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLMGTLGIV | 82-90 | ４°C | ||||
|
|
TS-M263-1 |
HLA-A*11:01 Perilipin-2 Tetramer-TSALPIIQK-PE |
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| TSALPIIQK | 63-71 | ４°C | ||||
|
|
TS-M239-1 |
HLA-A*02:01 SPOP Neoepitope Tetramer-FLLDEAIGL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLLDEAIGL | ４°C | |||||
|
|
TS-M246-2 |
HLA-A*02:01 GOLGA3 Neoepitope Tetramer-SLDLTTSPV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLDLTTSPV | ４°C | |||||
|
|
TS-M233-2 |
HLA-A*02:01 TEF-1 Neoepitope Tetramer-SVLENFTIFL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| SVLENFTIFL | ４°C | |||||
|
|
TS-M211-2 |
HLA-A*02:01 HER2 Neoepitope Tetramer-ALIHHNTYL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALIHHNTYL | ４°C | |||||
|
|
TS-M269-2 |
HLA-B*07:02 UBR4 Neoepitope Tetramer-RPHVPESAF-APC |
|
|||
|
|
cancer | APC | B*07:02 | 50 tests |
0 (Contact us) |
|
| RPHVPESAF | ４°C | |||||
|
|
TS-M219-2 |
HLA-A*02:01 SMARCD3 Neoepitope Tetramer-KLFEFLVYGV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLFEFLVYGV | ４°C | |||||
|
|
TC-8030-2 |
HLA-A*03:01 KRAS7-16 G12C Tetramer-VVVGACGVGK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGACGVGK | 7-16 | ４°C | ||||
|
|
TS-M254-2 |
HLA-A*03:01 MYO1B Neoepitope Tetramer-KINKNPKYK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| KINKNPKYK | ４°C | |||||
|
|
TS-M232-2 |
HLA-A*02:01 MRM1 Neoepitope Tetramer-LLFGMPPCL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLFGMPPCL | ４°C | |||||
|
|
TS-M224-2 |
HLA-A*02:01 CDC37L1 Neoepitope Tetramer-FLSDHLYLV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLSDHLYLV | ４°C | |||||
|
|
TS-M215-2 |
HLA-A*02:01 WDR46 Neoepitope Tetramer-FLIYLDVSV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLIYLDVSV | ４°C | |||||
|
|
TS-M208-2 |
HLA-A*02:01 p53 Neoepitope Tetramer-VVPCEPPEV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| VVPCEPPEV | ４°C | |||||
|
|
TS-M216-1 |
HLA-A*02:01 HAUS3 Neoepitope Tetramer-ILNAMIAKI-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILNAMIAKI | ４°C | |||||
|
|
TS-M256-2 |
HLA-A*11:01 Dengue virus NS3 Tetramer-GTSGSPIIDK-APC |
|
|||
|
|
virus | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| GTSGSPIIDK | 133-142 | ４°C | ||||
|
|
TS-M243-2 |
HLA-A*02:01 UGCGL2 Neoepitope Tetramer-GLLDEDFYA-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLLDEDFYA | ４°C | |||||
|
|
TS-M239-2 |
HLA-A*02:01 SPOP Neoepitope Tetramer-FLLDEAIGL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLLDEAIGL | ４°C | |||||
|
|
TS-M237-2 |
HLA-A*02:01 GCN1 Neoepitope Tetramer-ALLETPSLLL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALLETPSLLL | ４°C | |||||
|
|
TC-8020-1 |
HLA-A*02:01 PSMA663-671 Tetramer-MMNDQLMFL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| MMNDQLMFL | 663-671 | ４°C | ||||
|
|
TS-M214-2 |
HLA-A*02:01 COL18A1 Neoepitope Tetramer-VLLGVKLFGV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLLGVKLFGV | ４°C | |||||
|
|
TS-M233-1 |
HLA-A*02:01 TEF-1 Neoepitope Tetramer-SVLENFTIFL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| SVLENFTIFL | ４°C | |||||
|
|
TS-M275-2 |
HLA-B*07:02 MYADM Neoepitope Tetramer-SPMIVGSPW-APC |
|
|||
|
|
cancer | APC | B*07:02 | 50 tests |
0 (Contact us) |
|
| SPMIVGSPW | ４°C | |||||
|
|
TS-M242-2 |
HLA-A*02:01 MCT2 Neoepitope Tetramer-AMAGSLVFL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| AMAGSLVFL | ４°C | |||||
|
|
TS-M216-2 |
HLA-A*02:01 HAUS3 Neoepitope Tetramer-ILNAMIAKI-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILNAMIAKI | ４°C | |||||
|
|
TS-M226-1 |
HLA-A*02:01 Astrotactin-1 Neoepitope Tetramer-KLYGLDWAEL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLYGLDWAEL | ４°C | |||||
|
|
TS-M213-1 |
HLA-A*02:01 CDK4 Neoepitope Tetramer-ACDPHSGHFV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ACDPHSGHFV | ４°C | |||||
|
|
TS-M276-2 |
HLA-B*07:02 DOPEY2 Neoepitope Tetramer-KPFCVLISL-APC |
|
|||
|
|
cancer | APC | B*07:02 | 50 tests |
0 (Contact us) |
|
| KPFCVLISL | ４°C | |||||
|
|
TS-M226-2 |
HLA-A*02:01 Astrotactin-1 Neoepitope Tetramer-KLYGLDWAEL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLYGLDWAEL | ４°C | |||||
|
|
TS-M262-1 |
HLA-A*11:01 KIF26B Neoepitope Tetramer-SSYTGFANK-PE |
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| SSYTGFANK | ４°C | |||||
|
|
TS-M253-1 |
HLA-A*03:01 GPNMB Neoepitope Tetramer-TLDWLLQTPK-PE |
|
|||
|
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| TLDWLLQTPK | ４°C | |||||
|
|
TS-M232-1 |
HLA-A*02:01 MRM1 Neoepitope Tetramer-LLFGMPPCL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLFGMPPCL | ４°C | |||||
|
|
TS-M210-1 |
HLA-A*02:01 AHNAK Neoepitope Tetramer-FMPDFDLHL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FMPDFDLHL | ４°C | |||||
|
|
TC-8018-1 |
HLA-A*02:01 HBV194-202 Tetramer-FLLTKILTI-PE |
|
|||
|
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLLTKILTI | 194-202 | ４°C | ||||
|
|
TC-8008-2 |
HLA-A*02:01 HPV29-38 Tetramer-TIHDIILECV-APC |
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| TIHDIILECV | 29-38 | ４°C | ||||
|
|
TS-M213-2 |
HLA-A*02:01 CDK4 Neoepitope Tetramer-ACDPHSGHFV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ACDPHSGHFV | ４°C | |||||
|
|
TS-M270-2 |
HLA-B*07:02 KIF16B Neoepitope Tetramer-APARLERRHSA-APC |
|
|||
|
|
cancer | APC | B*07:02 | 50 tests |
0 (Contact us) |
|
| APARLERRHSA | ４°C | |||||
|
|
TS-M244-2 |
HLA-A*02:01 FNDC3B Neoepitope Tetramer-VVMSWAPPV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| VVMSWAPPV | ４°C | |||||
|
|
TS-M204-2 |
HLA-A*02:01 HCV polyprotein Tetramer-YLLPRRGPRL-APC |
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLLPRRGPRL | 35-44 | ４°C | ||||
|
|
TS-M218-1 |
HLA-A*02:01 ACTN1 Neoepitpe Tetramer-FIASNGVKLV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FIASNGVKLV | ４°C | |||||
|
|
TC-8024-1 |
HLA-A*02:01 KRAS5-14 WT Tetramer-KLVVVGAGGV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVVVGAGGV | 5-14 | ４°C | ||||
|
|
TS-M245-2 |
HLA-A*02:01 Sarcospan Neoepitope Tetramer-LMASISSFL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LMASISSFL | ４°C | |||||
|
|
TS-M257-1 |
HLA-A*11:01 HBcAg Tetramer-STLPETTVVRR-PE |
|
|||
|
|
virus | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| STLPETTVVRR | 141-151 | ４°C | ||||
|
|
TS-M228-1 |
HLA-A*02:01 PGML5 Neoepitope Tetramer-AVGSYVYSV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| AVGSYVYSV | ４°C | |||||
|
|
TS-M240-2 |
HLA-A*02:01 CK1α Neoepitope Tetramer-GLFGDIYLAI-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLFGDIYLAI | ４°C | |||||
|
|
TS-M205-1 |
HLA-A*02:01 HCV polyprotein Tetramer-DLMGYIPLV-PE |
|
|||
|
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| DLMGYIPLV | 132-140 | ４°C | ||||
|
|
TS-M221-2 |
HLA-A*02:01 GANAB Neoepitope Tetramer-ALYGFVPVL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALYGFVPVL | ４°C | |||||
|
|
TS-M235-1 |
HLA-A*02:01 Filamin-A Neoepitope Tetramer-HIAKSLFEV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| HIAKSLFEV | ４°C | |||||
|
|
TS-M210-2 |
HLA-A*02:01 AHNAK Neoepitope Tetramer-FMPDFDLHL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FMPDFDLHL | ４°C | |||||
|
|
TS-M229-2 |
HLA-A*02:01 SNX24 Neoepitope Tetramer-KLSHQLVLL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLSHQLVLL | ４°C | |||||
|
|
TS-M227-1 |
HLA-A*02:01 KMT2D Neoepitope Tetramer-ALSPVIPHI-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALSPVIPHI | ４°C | |||||
|
|
TS-M209-1 |
HLA-A*02:01 SRPX Neoepitope Tetramer-TLWCSPIKV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| TLWCSPIKV | ４°C | |||||
|
|
TS-M249-2 |
HLA-A*02:01 APOL1 Tetramer-ALADGVQKV-APC |
|
|||
|
|
Others | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALADGVQKV | 192-200 | ４°C | ||||
|
|
TS-M245-1 |
HLA-A*02:01 Sarcospan Neoepitope Tetramer-LMASISSFL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| LMASISSFL | ４°C | |||||
|
|
TS-M223-1 |
HLA-A*02:01 TEF-1 Neoepitope Tetramer-VLENFTIFLV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLENFTIFLV | ４°C | |||||
|
|
TS-M267-2 |
HLA-A*24:02 LOK Tetramer-SYQKVIELF-APC |
|
|||
|
|
cancer | APC | A*24:02 | 50 tests |
0 (Contact us) |
|
| SYQKVIELF | 289-297 | ４°C | ||||
|
|
TS-M217-1 |
HLA-A*02:01 ME3 Neoepitope Tetramer-FLDEFMEGV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLDEFMEGV | ４°C | |||||
|
|
TS-M204-1 |
HLA-A*02:01 HCV polyprotein Tetramer-YLLPRRGPRL-PE |
|
|||
|
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLLPRRGPRL | 35-44 | ４°C | ||||
|
|
TS-M234-1 |
HLA-A*02:01 GAS7 Neoepitope Tetramer-SLADEAEVYL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLADEAEVYL | ４°C | |||||
|
|
TS-M277-2 |
HLA-B*08:01 FAM50B Neoepitope Tetramer-DMKARQKALV-APC |
|
|||
|
|
cancer | APC | B*08:01 | 50 tests |
0 (Contact us) |
|
| DMKARQKALV | ４°C | |||||
|
|
TS-M237-1 |
HLA-A*02:01 GCN1 Neoepitope Tetramer-ALLETPSLLL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALLETPSLLL | ４°C | |||||
|
|
TS-M205-2 |
HLA-A*02:01 HCV polyprotein Tetramer-DLMGYIPLV-APC |
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| DLMGYIPLV | 132-140 | ４°C | ||||
|
|
TC-8004-1 |
HLA-A*11:01 KRAS8-16 G12V Tetramer-VVGAVGVGK-PE |
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVGAVGVGK | 8-16 | ４°C | ||||
|
|
TC-8023-2 |
HLA-A*11:01 KRAS7-16 G12S Tetramer- VVVGASGVGK-APC |
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGASGVGK | 7-16 | ４°C | ||||
|
|
TS-M250-1 |
HLA-A*02:01 EBV BRLF1 Tetramer-YVLDHLIVV-PE |
|
|||
|
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YVLDHLIVV | 109-117 | ４°C | ||||
|
|
TC-8032-1 |
HLA-A*03:01 KRAS7-16 G12V Tetramer-VVVGAVGVGK-PE |
|
|||
|
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGAVGVGK | 7-16 | ４°C | ||||
|
|
TS-M202-2 |
HLA-A*01:01 NRAS Neoepitope Tetramer-ILDTAGREEY-APC |
|
|||
|
|
cancer | APC | A*01:01 | 50 tests |
0 (Contact us) |
|
| ILDTAGREEY | ４°C | |||||
|
|
TC-8016-2 |
HLA-A*11:01 EGFR852-860 L858R Tetramer-KITDFGRAK-APC |
|
|||
|
|
Others | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| KITDFGRAK | 852-860 | ４°C | ||||
|
|
TS-M251-2 |
HLA-A*03:01 SIRT2 Neoepitope Tetramer-KIFSEVTLK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| KIFSEVTLK | ４°C | |||||
|
|
TC-8022-1 |
HLA-A*11:01 KRAS7-16 G12C Tetramer-VVVGACGVGK-PE |
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGACGVGK | 7-16 | ４°C | ||||
|
|
TC-8015-1 |
HLA-A*11:01 KRAS7-16 G13D Tetramer-VVVGAGDVGK-PE |
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGAGDVGK | 7-16 | ４°C | ||||
|
|
TC-8011-2 |
HLA-A*02:01 KRAS5-14 G12V Tetramer-KLVVVGAVGV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVVVGAVGV | 5-14 | ４°C | ||||
|
|
TS-M252-1 |
HLA-A*03:01 PRPF6 Neoepitope Tetramer-KILDAVVAQK-PE |
|
|||
|
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| KILDAVVAQK | ４°C | |||||
|
|
TC-8012-1 |
HLA-A*11:01 KRAS7-16 G12R Tetramer-VVVGARGVGK-PE |
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGARGVGK | 7-16 | ４°C | ||||
|
|
TC-8002-2 |
HLA-A*11:01 KRAS8-16 G12D Tetramer-VVGADGVGK-APC |
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVGADGVGK | 8-16 | ４°C | ||||
|
|
TC-8025-2 |
HLA-A*11:01 HPV16 E789-97 Tetramer-IVCPICSQK-APC |
|
|||
|
|
virus | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| IVCPICSQK | 89-97 | ４°C | ||||
|
|
TC-8021-2 |
HLA-A*11:01 KRAS7-16 G12A Tetramer-VVVGAAGVGK-APC |
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGAAGVGK | 7-16 | ４°C | ||||
|
|
TC-8029-2 |
HLA-A*03:01 KRAS8-16 G12C Tetramer-VVGACGVGK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVGACGVGK | 8-16 | ４°C | ||||
|
|
TS-M254-1 |
HLA-A*03:01 MYO1B Neoepitope Tetramer-KINKNPKYK-PE |
|
|||
|
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| KINKNPKYK | ４°C | |||||
|
|
TS-M203-1 |
HLA-A*02:01 HPV16 E7 Tetramer-LLMGTLGIV-PE |
|
|||
|
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLMGTLGIV | 82-90 | ４°C | ||||
- The availability is based on the information in Japan at 17:02, Jul 14, 2026 in JST.
- The special price is shown in red color.
- Please note that products cannot be ordered from this website. To purchase the items listed in this website, please contact us or local distributers.
- For storage temparature: RT: room temparature
- Please note that products in this website might be changed or discontinued without notification in advance for quality improvement.